[1] |
Bray F, Laversanne M, Weiderpass E, et al. The ever-increasing importance of cancer as a leading cause of premature death worldwide[J]. Cancer, 2021, 127(16): 3029-3030. DOI: 10.1002/cncr.33587.
doi: 10.1002/cncr.33587
pmid: 34086348
|
[2] |
Ferlay J, Colombet M, Soerjomataram I, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods[J]. Int J Cancer, 2019, 144(8): 1941-1953. DOI: 10.1002/ijc.31937.
doi: 10.1002/ijc.31937
pmid: 30350310
|
[3] |
Global Burden of Disease Cancer Collaboration. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2016: a systematic analysis for the global burden of disease study[J]. JAMA Oncol, 2018, 4(11): 1553-1568. DOI: 10.1001/jamaoncol.2018.2706.
doi: 10.1001/jamaoncol.2018.2706
pmid: 29860482
|
[4] |
Jin G, Zou M, Zhang Y, et al. Time trends, associations and global burden of intraocular foreign bodies[J]. Br J Ophthalmol, 2022, 106(3): 435-439. DOI: 10.1136/bjophthalmol-2020-317063.
doi: 10.1136/bjophthalmol-2020-317063
|
[5] |
GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019[J]. Lancet, 2020, 396(10258): 1204-1222. DOI: 10.1016/S0140-6736(20)30925-9.
doi: 10.1016/S0140-6736(20)30925-9
pmid: 33069326
|
[6] |
Kim HJ, Fay MP, Feuer EJ, et al. Permutation tests for joinpoint regression with applications to cancer rates[J]. Stat Med, 2000, 19(3): 335-351. DOI: 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z.
doi: 10.1002/(sici)1097-0258(20000215)19:3<335::aid-sim336>3.0.co;2-z
pmid: 10649300
|
[7] |
孙惠昕, 张茂祥, 王婉莹, 等. 癌症筛查与早诊早治的研究进展[J]. 现代肿瘤医学, 2021, 29(18): 3287-3290. DOI: 10.3969/j.issn.1672-4992.2021.18.033.
doi: 10.3969/j.issn.1672-4992.2021.18.033
|
[8] |
De Vuyst H, Alemany L, Lacey C, et al. The burden of human papillomavirus infections and related diseases in sub-Saharan Africa[J]. Vaccine, 2013, 31 Suppl 5(5): F32-F46. DOI: 10.1016/j.vaccine.2012.07.092.
doi: 10.1016/j.vaccine.2012.07.092
|
[9] |
Lim JN, Ojo AA. Barriers to utilisation of cervical cancer screening in Sub Sahara Africa: a systematic review[J]. Eur J Cancer Care (Engl), 2017, 26(1): e12444. DOI: 10.1111/ecc.12444.
doi: 10.1111/ecc.12444
|
[10] |
Barta JA, Powell CA, Wisnivesky JP. Global epidemiology of lung cancer[J]. Ann Glob Health, 2019, 85(1): 8. DOI: 10.5334/aogh.2419.
doi: 10.5334/aogh.2419
|
[11] |
Jemal A, Thun MJ, Ries LA, et al. Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control[J]. J Natl Cancer Inst, 2008, 100(23): 1672-1694. DOI: 10.1093/jnci/djn389.
doi: 10.1093/jnci/djn389
pmid: 19033571
|
[12] |
de Koning HJ, Meza R, Plevritis SK, et al. Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task Force[J]. Ann Intern Med, 2014, 160(5): 311-320. DOI: 10.7326/M13-2316.
doi: 10.7326/M13-2316
pmid: 24379002
|
[13] |
Buszewski B, Ligor T, Jezierski T, et al. Identification of volatile lung cancer markers by gas chromatography-mass spectrometry: comparison with discrimination by canines[J]. Anal Bioanal Chem, 2012, 404(1): 141-146. DOI: 10.1007/s00216-012-6102-8.
doi: 10.1007/s00216-012-6102-8
pmid: 22660158
|
[14] |
Joko-Fru WY, Miranda-Filho A, Soerjomataram I, et al. Breast cancer survival in sub-Saharan Africa by age, stage at diagnosis and human development index: a population-based registry study[J]. Int J Cancer, 2020, 146(5): 1208-1218. DOI: 10.1002/ijc.32406.
doi: 10.1002/ijc.32406
pmid: 31087650
|
[15] |
Heath AK, Muller DC, van den Brandt PA, et al. Nutrient-wide association study of 92 foods and nutrients and breast cancer risk[J]. Breast Cancer Research, 2020, 22(1): 5. DOI: 10.1186/s13058-019-1244-7.
doi: 10.1186/s13058-019-1244-7
pmid: 31931881
|
[16] |
Thakur P, Seam RK, Gupta MK, et al. Breast cancer risk factor evaluation in a Western Himalayan state: a case-control study and comparison with the Western World[J]. South Asian J Cancer, 2017, 6(3): 106-109. DOI: 10.4103/sajc.sajc_157_16.
doi: 10.4103/sajc.sajc_157_16
pmid: 28975116
|
[17] |
Keum N, Giovannucci E. Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies[J]. Nat Rev Gastroenterol Hepatol, 2019, 16(12): 713-732. DOI: 10.1038/s41575-019-0189-8.
doi: 10.1038/s41575-019-0189-8
pmid: 31455888
|
[18] |
Mohan G, Chattopadhyay S. Cost-effectiveness of leveraging social determinants of health to improve breast, cervical, and colorectal cancer screening: a systematic review[J]. JAMA Oncol, 2020, 6(9): 1434-1444. DOI: 10.1001/jamaoncol.2020.1460.
doi: 10.1001/jamaoncol.2020.1460
|